BENGALURU, 2 JULY

Bengaluru-headquartered Health Care Global Enterprises Limited (HCG) on Wednesday denied allegations of unfair clinical trials at its facility, claiming that it is successfully conducting a significant number of studies with utmost transparency and prioritising patient safety approved by its ethics committee.

The development came after Justice P Krishna Bhat (Retd), former chairperson of the Institutional Ethics Committee of HCG, levelled allegations of unfair clinical trials being conducted by the firm, in response to which the State government wrote to the Drug Controller General of India (DCGI), seekingan investigation into the allegtions.

The HCG said it strictly adhered to all guidelines set by regulatory authorities, including the DCGI and the Indian Council of Medical Research.

"We've noticed some unverified information about HCG, a pioneer in Cancer care in India and Africa. We assure you that we strictly adhere to all guidelines set by regulatory authorities, including DCGI and ICMR.

"We're successfully conducting a significant number of trials with the utmost transparency, prioritising patient safety, approved by our Ethics Committee. Our commitment to delivering exceptional care remains unwavering," said HCG Founder and Chairman Dr BS Ajaikumar in a statement.

According to its official website, the HCG is a healthcare provider offering cancer care, tertiary care, infertility treatment and advanced screening and diagnostic services.